Your browser doesn't support javascript.
loading
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
Pulsipher, Michael A; Lehmann, Leslie E; Bertuch, Alison A; Sasa, Ghadir; Olson, Timothy; Nakano, Taizo; Gilio, Alfred; Burroughs, Lauri M; Lipton, Jeffrey M; Huang, James N; Dickerson, Kathryn; Bertaina, Alice; Zhuang, Cindy; Malsch, Maggie; Fleming, Mark; Weller, Edie; Shimamura, Akiko; Williams, David A.
Afiliação
  • Pulsipher MA; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Lehmann LE; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Bertuch AA; Baylor College of Medicine, Center for Cell and Gene Therapy and Texas Children's Hospital, Houston, Texas.
  • Sasa G; Baylor College of Medicine, Center for Cell and Gene Therapy and Texas Children's Hospital, Houston, Texas.
  • Olson T; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Nakano T; Children's Hospital Colorado, Aurora, Colorado.
  • Gilio A; Pediatric Hematology & Oncology, Hackensack, NJ.
  • Burroughs LM; Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington.
  • Lipton JM; Division of Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center of New York, New York.
  • Huang JN; UCSF Benioff Children's Hospital and University of California, San Francisco, California.
  • Dickerson K; UT Southwestern Medical Center, Dallas, Texas.
  • Bertaina A; Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, California.
  • Zhuang C; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Malsch M; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Fleming M; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Weller E; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Shimamura A; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Williams DA; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
Pediatr Blood Cancer ; 67(10): e28444, 2020 10.
Article em En | MEDLINE | ID: mdl-32776425
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Seleção de Pacientes / Tempo para o Tratamento / Imunossupressores / Anemia Aplástica Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Seleção de Pacientes / Tempo para o Tratamento / Imunossupressores / Anemia Aplástica Idioma: En Ano de publicação: 2020 Tipo de documento: Article